adplus-dvertising
Connect with us

Business

New vaccine may be option for U.S. troops with religious concerns – CP24 Toronto's Breaking News

Published

 on


Lolita C. Baldor, The Associated Press


Published Thursday, June 9, 2022 6:06AM EDT


Last Updated Thursday, June 9, 2022 6:07AM EDT

WASHINGTON (AP) — A COVID-19 vaccine that could soon win federal approval may offer a boost for the U.S. military: an opportunity to get shots into some of the thousands of service members who have refused other coronavirus vaccines for religious reasons.

At least 175 active duty and reserve service members have already received the Novavax vaccine, some even traveling overseas at their own expense to get it. The vaccine meets Defense Department requirements because it has the World Health Organization’s emergency use approval and is used in Europe and other regions. The Food and Drug Administration is considering giving it emergency use authorization in the U.S.

The Novavax vaccine may be an acceptable option for some of the 27,000 service members who have sought religious exemptions from the mandatory vaccine. Military officials say many troops who refuse the shots cite certain COVID-19 vaccines’ remote connection to abortions.

Laboratory-grown cell lines descended from fetuses that were aborted decades ago were used in some early-stage testing of the Pfizer and Moderna vaccines and to grow viruses used to manufacture the Johnson & Johnson vaccine. The vaccines do not contain fetal cells. Novavax, however, says that ”no human fetal-derived cell lines or tissue” were used in the development, manufacture or production of its vaccine.

Defense Secretary Lloyd Austin made COVID-19 vaccinations mandatory last year, saying the shots were critical to maintaining military readiness and the health of the force. Military leaders have argued that troops for decades have been required to get as many as 17 vaccines, particularly for those who are deploying overseas.

One group involved in lawsuits targeting the military’s vaccine requirement said it’s possible some shot opponents may see Novavax as an amenable option.

“I definitely think it is for some, but certainly not for all,” said Mike Berry, director of military affairs for First Liberty Institute. “There are some for whom abortion is really the ultimate issue, and once that issue is resolved for them spiritually, then they’re willing.”

Berry added, however, that for others, abortion is “just a tangential issue,” and they have broader opposition to vaccines as a whole. “A rudimentary way of looking at it is that they’ve asked for God’s will, and they believe that it would be wrong for them to get the vaccine,” Berry said. “In other words, they believe that God has told them no.”

Novavax also may appeal to people who are uncomfortable with the new genetic-based technology used in Pfizer and Moderna’s so-called mRNA vaccines. They deliver genetic instructions for the body to make copies of the coronavirus’ outer coating, the spike protein.

The Novavax vaccine is made with a more familiar technology, like those used for years to prevent hepatitis B and shingles. It trains the body to fight the coronavirus by delivering copies of the outer coating which are grown in insect cells, then are purified and packaged into nanoparticles that to the immune system resemble a virus, according to Novavax research chief Dr. Gregory Glenn.

While some religious groups oppose the shots, when COVID-19 vaccines first started rolling out the Vatican’s doctrine office called the options “morally acceptable” and Pope Francis, who has received Pfizer shots, has strongly encouraged widespread vaccination.

Berry said he doesn’t know how many would consider Novavax acceptable, but guessed it may be a small percentage. First Liberty Institute and the law firm Schaerr Jaffe LLP are representing a number of Navy sailors in one lawsuit, and nine airmen in another.

Military officials declined to publicly detail the nature of any service members’ religious exemption requests, but spoke on condition of anonymity to provide some descriptions. They said that the most predominant issue mentioned in waiver requests is the remote link to fetal cell lines, while others argue that their body is a temple that must remain pure. Others, officials said, describe reasons that appear to have less connection to faith.

Berry said his firm carefully screens individuals for the lawsuits, to make sure their objections are based on sincerely held religious beliefs, rather than political or other opposition masquerading as faith-based views.

The military can’t administer the Novavax shot now, and won’t pay for anyone’s travel overseas to get it. But tens of thousands of American forces are based in Europe, where Novavax is available.

Earlier this week, advisers to the FDA backed the Novavax vaccine. Next, the FDA must decide whether to authorize it. A final FDA decision isn’t expected immediately, as the agency finishes combing through the data.

Across the military, more than 5,000 service members have been discharged for refusing the vaccine, according to the latest statistics provided by the services. Of those who requested religious exemptions, only slightly more than 100 have been approved.

In the lawsuit against the Navy, a federal judge in Texas agreed the case can go forward as a class-action lawsuit and issued a preliminary injunction barring the service from taking action against sailors who objected to the vaccine on religious grounds. Berry said the Justice Department has said it will appeal the ruling to the 5th Circuit Court of Appeals.

In the Air Force lawsuit, Berry said, lawyers have asked that it also be a class action, and they are seeking a temporary restraining order preventing the Air Force from taking any adverse actions. The court has not yet ruled.

___

AP Medical Writer Lauran Neergaard contributed to this report.

Adblock test (Why?)

728x90x4

Source link

Continue Reading

Business

Roots sees room for expansion in activewear, reports $5.2M Q2 loss and sales drop

Published

 on

 

TORONTO – Roots Corp. may have built its brand on all things comfy and cosy, but its CEO says activewear is now “really becoming a core part” of the brand.

The category, which at Roots spans leggings, tracksuits, sports bras and bike shorts, has seen such sustained double-digit growth that Meghan Roach plans to make it a key part of the business’ future.

“It’s an area … you will see us continue to expand upon,” she told analysts on a Friday call.

The Toronto-based retailer’s push into activewear has taken shape over many years and included several turns as the official designer and supplier of Team Canada’s Olympic uniform.

But consumers have had plenty of choice when it comes to workout gear and other apparel suited to their sporting needs. On top of the slew of athletic brands like Nike and Adidas, shoppers have also gravitated toward Lululemon Athletica Inc., Alo and Vuori, ramping up competition in the activewear category.

Roach feels Roots’ toehold in the category stems from the fit, feel and following its merchandise has cultivated.

“Our product really resonates with (shoppers) because you can wear it through multiple different use cases and occasions,” she said.

“We’ve been seeing customers come back again and again for some of these core products in our activewear collection.”

Her remarks came the same day as Roots revealed it lost $5.2 million in its latest quarter compared with a loss of $5.3 million in the same quarter last year.

The company said the second-quarter loss amounted to 13 cents per diluted share for the quarter ended Aug. 3, the same as a year earlier.

In presenting the results, Roach reminded analysts that the first half of the year is usually “seasonally small,” representing just 30 per cent of the company’s annual sales.

Sales for the second quarter totalled $47.7 million, down from $49.4 million in the same quarter last year.

The move lower came as direct-to-consumer sales amounted to $36.4 million, down from $37.1 million a year earlier, as comparable sales edged down 0.2 per cent.

The numbers reflect the fact that Roots continued to grapple with inventory challenges in the company’s Cooper fleece line that first cropped up in its previous quarter.

Roots recently began to use artificial intelligence to assist with daily inventory replenishments and said more tools helping with allocation will go live in the next quarter.

Beyond that time period, the company intends to keep exploring AI and renovate more of its stores.

It will also re-evaluate its design ranks.

Roots announced Friday that chief product officer Karuna Scheinfeld has stepped down.

Rather than fill the role, the company plans to hire senior level design talent with international experience in the outdoor and activewear sectors who will take on tasks previously done by the chief product officer.

This report by The Canadian Press was first published Sept. 13, 2024.

Companies in this story: (TSX:ROOT)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Talks on today over HandyDART strike affecting vulnerable people in Metro Vancouver

Published

 on

 

VANCOUVER – Mediated talks between the union representing HandyDART workers in Metro Vancouver and its employer, Transdev, are set to resume today as a strike that has stopped most services drags into a second week.

No timeline has been set for the length of the negotiations, but Joe McCann, president of the Amalgamated Transit Union Local 1724, says they are willing to stay there as long as it takes, even if talks drag on all night.

About 600 employees of the door-to-door transit service for people unable to navigate the conventional transit system have been on strike since last Tuesday, pausing service for all but essential medical trips.

Hundreds of drivers rallied outside TransLink’s head office earlier this week, calling for the transportation provider to intervene in the dispute with Transdev, which was contracted to oversee HandyDART service.

Transdev said earlier this week that it will provide a reply to the union’s latest proposal on Thursday.

A statement from the company said it “strongly believes” that their employees deserve fair wages, and that a fair contract “must balance the needs of their employees, clients and taxpayers.”

This report by The Canadian Press was first published Sept. 12, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Transat AT reports $39.9M Q3 loss compared with $57.3M profit a year earlier

Published

 on

 

MONTREAL – Travel company Transat AT Inc. reported a loss in its latest quarter compared with a profit a year earlier as its revenue edged lower.

The parent company of Air Transat says it lost $39.9 million or $1.03 per diluted share in its quarter ended July 31.

The result compared with a profit of $57.3 million or $1.49 per diluted share a year earlier.

Revenue in what was the company’s third quarter totalled $736.2 million, down from $746.3 million in the same quarter last year.

On an adjusted basis, Transat says it lost $1.10 per share in its latest quarter compared with an adjusted profit of $1.10 per share a year earlier.

Transat chief executive Annick Guérard says demand for leisure travel remains healthy, as evidenced by higher traffic, but consumers are increasingly price conscious given the current economic uncertainty.

This report by The Canadian Press was first published Sept. 12, 2024.

Companies in this story: (TSX:TRZ)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending